Top

Published in:

01-04-2016 | Original Article

The effect of preventive oral care on treatment outcomes of a cohort of oral cancer patients

Authors: Marilia Oliveira Morais, Marcela Ramos Abrahão Elias, Cláudio Rodrigues Leles, Juliana Castro Dourado Pinezi, Elismauro Francisco Mendonça

Published in: Supportive Care in Cancer | Issue 4/2016

Abstract

Purpose

The purpose of this study was to assess patient adherence to an oral preventive measures (OPM) protocol and its impact on cancer treatment outcomes.

Methods

A retrospective cohort of oral cancer of 133 patients submitted to radiotherapy (RT) was selected, excluding those with metastasis. Patients were grouped according to their local tumor response after finishing RT (favorable or unfavorable) and adherence to an OPM (none, ≤6 months, and >6 months). OPM included education and counseling about adverse effects, elimination of infection foci, restorative procedures, fluoride therapy, oral rehydration, and maintenance and supervision of oral hygiene throughout treatment. Clinical and pathological characteristics were recorded, and patient outcomes (frequency of adverse effects, RT interruption, and overall survival) were analyzed.

Results

Patients with higher adherence to the OPM had greater occurrence of RT interruption as a consequence of symptoms (p = 0.01); however, these patients were more likely to complete the established RT protocol (p = 0.02). Overall survival (p = 0.01) was higher in the group with higher adherence.

Conclusions

This study suggests that the implementation of oral preventive measures may contribute to improving the prognosis of squamous cell carcinoma (SCC) treatment by reducing the negative impact of oral complications.

Pernot M, Hoffstetter S, Peiffert D, Luporsi E, Marchal C, Kozminski P, Dartois D, Bey P (1995) Epidermoid carcinomas of the floor of mouth treated by exclusive irradiation: statistical study of a series of 207 cases. Radiother Oncol 35(3):177–185CrossRefPubMed

Patra NB, Goswami J, Basu S, Chatterjee K, Sarkar SK (2009) Outcomes of high dose rate interstitial boost brachytherapy after external beam radiation therapy in head and neck cancer—an Indian (single institutional) learning experience. Brachytherapy 8(2):248–254CrossRefPubMed

Stenson KM, Kunnavakkam R, Cohen EE, Portugal LD, Blair E, Haraf DJ, Salama J, Vokes EE (2010) Chemoradiation for patients with advanced oral cavity cancer. Laryngoscope 120(1):93–99. doi:10.1002/lary.20716 PubMed

Specht L (2002) Oral complications in the head and neck radiation patient. Introduction and scope of the problem. Support Care Cancer 10(1):36–39CrossRefPubMed

Dirix P, Nuyts S, Van den Bogaert W (2006) Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer 107(11):2525–2534. doi:10.1002/cncr.22302 CrossRefPubMed

Chen YP, Tsang NM, Tseng CK, Lin SY (2000) Causes of interruption of radiotherapy in nasopharyngeal carcinoma patients in Taiwan. Jpn J Clin Oncol 30(5):230–234CrossRefPubMed

Vera-Llonch M, Oster G, Hagiwara M, Sonis S (2006) Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 106(2):329–336. doi:10.1002/cncr.21622 CrossRefPubMed

Russo G, Haddad R, Posner M, Machtay M (2008) Radiation treatment breaks and ulcerative mucositis in head and neck cancer. Oncologist 13(8):886–898. doi:10.1634/theoncologist.2008-0024 CrossRefPubMed

Sonis ST (2011) Oral mucositis. Anticancer Drugs 22(7):607–612. doi:10.1097/CAD.0b013e3283462086 CrossRefPubMed

10.

Tolentino Ede S, Centurion BS, Ferreira LH, Souza AP, Damante JH, Rubira-Bullen IR (2011) Oral adverse effects of head and neck radiotherapy: literature review and suggestion of a clinical oral care guideline for irradiated patients. J Appl Oral Sci 19(5):448–454CrossRefPubMed

11.

Huang Q, Li F, Liu X, Li W, Shi W, Liu FF, O’Sullivan B, He Z, Peng Y, Tan AC, Zhou L, Shen J, Han G, Wang XJ, Thorburn J, Thorburn A, Jimeno A, Raben D, Bedford JS, Li CY (2011) Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med 17(7):860–866. doi:10.1038/nm.2385 PubMedCentralCrossRefPubMed

12.

Leipzig B, Cummings CW, Chung CT, Sagerman RH (1978) Interruption of combined therapy: a factor in decreased survival. Otolaryngology 86 (6 Pt 1):ORL-881-885

13.

Herrmann T, Jakubek A, Trott KR (1994) The importance of the timing of a gap in radiotherapy of squamous cell carcinomas of the head and neck. Strahlenther Onkol 170(9):545–549PubMed

14.

Suwinski R, Sowa A, Rutkowski T, Wydmanski J, Tarnawski R, Maciejewski B (2003) Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients. Int J Radiat Oncol Biol Phys 56(2):399–412CrossRefPubMed

15.

Schiodt M, Hermund NU (2002) Management of oral disease prior to radiation therapy. Support Care Cancer 10(1):40–43CrossRefPubMed

16.

Hancock PJ, Epstein JB, Sadler GR (2003) Oral and dental management related to radiation therapy for head and neck cancer. J Can Dent Assoc 69(9):585–590PubMed

17.

Cho EI, Sasaki CT, Haffty BG (2004) Prognostic significance of pretreatment hemoglobin for local control and overall survival in T1-T2N0 larynx cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 58(4):1135–1140. doi:10.1016/j.ijrobp.2003.08.002 CrossRefPubMed

18.

Langendijk JA, Doornaert P, Rietveld DH, Verdonck-de Leeuw IM, Leemans CR, Slotman BJ (2009) A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol 90(2):189–195CrossRefPubMed

19.

Oton-Leite AF, Correa de Castro AC, Morais MO, Pinezi JC, Leles CR, Mendonca EF (2012) Effect of intraoral low-level laser therapy on quality of life of patients with head and neck cancer undergoing radiotherapy. Head Neck 34(3):398–404. doi:10.1002/hed.21737 CrossRefPubMed

20.

Oton-Leite AF, Elias LS, Morais MO, Pinezi JC, Leles CR, Silva MA, Mendonca EF (2013) Effect of low level laser therapy in the reduction of oral complications in patients with cancer of the head and neck submitted to radiotherapy. Spec Care Dentist 33(6):294–300. doi:10.1111/j.1754-4505.2012.00303.x CrossRefPubMed

21.

Cheng KK, Molassiotis A, Chang AM, Wai WC, Cheung SS (2001) Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients. Eur J Cancer 37(16):2056–2063CrossRefPubMed

22.

Cheng KK, Molassiotis A, Chang AM (2002) An oral care protocol intervention to prevent chemotherapy-induced oral mucositis in paediatric cancer patients: a pilot study. Eur J Oncol Nurs 6(2):66–73CrossRefPubMed

23.

Eduardo Fde P, Bezinelli LM, de Carvalho DL, Lopes RM, Fernandes JF, Brumatti M, Vince CS, de Azambuja AM, Vogel C, Hamerschlak N, Correa L (2015) Oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: clinical outcomes in a context of specialized oral care using low-level laser therapy. Pediatr Transplant 19(3):316–325. doi:10.1111/petr.12440 CrossRefPubMed

24.

Kubota K, Kobayashi W, Sakaki H, Nakagawa H, Kon T, Mimura M, Ito R, Furudate K, Kimura H (2015) Professional oral health care reduces oral mucositis pain in patients treated by superselective intra-arterial chemotherapy concurrent with radiotherapy for oral cancer. Support Care Cancer. doi:10.1007/s00520-015-2774-x

25.

Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S (2014) MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120(10):1453–1461. doi:10.1002/cncr.28592 PubMedCentralCrossRefPubMed

26.

Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655CrossRefPubMed

27.

Rahn R, Adamietz IA, Boettcher HD, Schaefer V, Reimer K, Fleischer W (1997) Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy. Dermatology 195(Suppl 2):57–61CrossRefPubMed

28.

Fitzpatrick AL, Powe NR, Cooper LS, Ives DG, Robbins JA (2004) Barriers to health care access among the elderly and who perceives them. Am J Public Health 94(10):1788–1794PubMedCentralCrossRefPubMed

29.

Corrigan DM, Walker MP, Liu Y, Mitchell TV (2013) Factors influencing patients seeking oral health care in the oncology dental support clinic at an urban university dental school setting. Spec Care Dentist 34:106–113. doi:10.1111/scd.12037 CrossRefPubMed

30.

Capuano G, Gentile PC, Bianciardi F, Tosti M, Palladino A, Di Palma M (2010) Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Cancer 18(4):433–437. doi:10.1007/s00520-009-0681-8 CrossRefPubMed

31.

Kartin PT, Tasci S, Soyuer S, Elmali F (2014) Effect of an oral mucositis protocol on quality of life of patients with head and neck cancer treated with radiation therapy. Clin J Oncol Nurs 18(6):E118–E125. doi:10.1188/14.CJON.E118-E125 CrossRefPubMed

32.

Kashiwazaki H, Matsushita T, Sugita J, Shigematsu A, Kasashi K, Yamazaki Y, Kanehira T, Yamamoto S, Kondo T, Endo T, Tanaka J, Hashino S, Nishio M, Imamura M, Kitagawa Y, Inoue N (2012) Professional oral health care reduces oral mucositis and febrile neutropenia in patients treated with allogeneic bone marrow transplantation. Support Care Cancer 20(2):367–373. doi:10.1007/s00520-011-1116-x CrossRefPubMed

33.

Kim JW, Cha Y, Kim SJ, Han SW, Oh DY, Lee SH, Kim DW, Im SA, Kim TY, Heo DS, Bang YJ (2012) Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy. Support Care Cancer 20(2):395–403. doi:10.1007/s00520-011-1126-8 CrossRefPubMed

34.

Patel Y, Bahlhorn H, Zafar S, Zwetchkenbaum S, Eisbruch A, Murdoch-Kinch CA (2012) Survey of Michigan dentists and radiation oncologists on oral care of patients undergoing head and neck radiation therapy. J Mich Dent Assoc 94(7):34–45PubMed

35.

Barker GJ, Epstein JB, Williams KB, Gorsky M, Raber-Durlacher JE (2005) Current practice and knowledge of oral care for cancer patients: a survey of supportive health care providers. Support Care Cancer 13(1):32–41. doi:10.1007/s00520-004-0691-5 CrossRefPubMed

36.

Eich HT, Loschcke M, Scheer M, Kocher M, Bongartz R, Wacker S, Zoller JE, Muller RP (2008) Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients. Strahlenther Onkol 184(1):23–29. doi:10.1007/s00066-008-1725-6 CrossRefPubMed

37.

Hitter A, Soriano E, Bettega G, Karkas A, Reyt E, Righini CA (2007) Outcome of surgical and adjuvant radiotherapy treatment of T3-T4 squamous cell carcinoma of the floor of the mouth: evaluation of oncological control and treatment related morbidity. Rev Laryngol Otol Rhinol (Bord) 128(3):155–162

38.

Kreppel M, Eich HT, Kubler A, Zoller JE, Scheer M (2010) Prognostic value of the sixth edition of the UICC’s TNM classification and stage grouping for oral cancer. J Surg Oncol 102(5):443–449. doi:10.1002/jso.21547 CrossRefPubMed

Title: The effect of preventive oral care on treatment outcomes of a cohort of oral cancer patients
Authors: Marilia Oliveira Morais
Marcela Ramos Abrahão Elias
Cláudio Rodrigues Leles
Juliana Castro Dourado Pinezi
Elismauro Francisco Mendonça
Publication date: 01-04-2016
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 4/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-015-2956-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2016

Treatment of taxane acute pain syndrome (TAPS) in cancer patients receiving taxane-based chemotherapy—a systematic review

Medication use by early-stage breast cancer survivors: a 1-year longitudinal study

Influence of an elemental diet on 5-fluorouracil-induced morphological changes in the mouse salivary gland and colon

Polypharmacy cut-points in older people with cancer: how many medications are too many?

Acute stress trajectories 1 year after a breast cancer diagnosis

“I didn’t actually know there was such a thing as rehab”: survivor, family, and clinician perceptions of rehabilitation following treatment for head and neck cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer